DiscoverASHPOfficialClinical Conversations (C.E.): Pharmacogenomics: Implementation in Oncology and the Pharmacist's Role (CE)
Clinical Conversations (C.E.): Pharmacogenomics: Implementation in Oncology and the Pharmacist's Role (CE)

Clinical Conversations (C.E.): Pharmacogenomics: Implementation in Oncology and the Pharmacist's Role (CE)

Update: 2025-10-11
Share

Description

This session focuses on various pharmacogenomics implementation models in oncology. Presenters discuss how pharmacogenomics was implemented at their respective institution, how each addressed unique barriers to implementation, and considerations for scalability, sustainability, and expansion of pharmacogenomics testing in oncology over the next 5+ years. CE for this episode expires two years after publication.


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Clinical Conversations (C.E.): Pharmacogenomics: Implementation in Oncology and the Pharmacist's Role (CE)

Clinical Conversations (C.E.): Pharmacogenomics: Implementation in Oncology and the Pharmacist's Role (CE)

American Society of Health-System Pharmacists©